Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

Your 2017 Speaker Faculty

Lauren Carey

Lauren Carey

General Manager, Novartis Oncology

Read more

More information coming soon...

Albert Spanos

Albert Spanos

Head of Operations & Corporate Affairs, Celgene

Read more

Albert has enjoyed a career which currently spans nearly 30 years in the Australian Pharmaceutical Industry having held senior roles in Sales, Marketing, Business Development, General Management, Corporate Affairs, Established Brands, Medical Affairs and Market Access across many therapeutic areas in Primary Care, Pharmacy and Specialist medicine. Albert has worked in both large Pharmaceutical companies (Pharmacia/Pfizer) and biopharmaceutical/biotechnology companies (Celgene). During his career Albert has been a member of numerous global teams at both Pharmacia/Pfizer and Celgene gaining a clear understanding of the global implications of the Australian Pharmaceutical landscape helping impart this knowledge with senior Committees within Medicines Australia and using this expertise to successfully negotiate the PBS listing of several Celgene products during his time at Celgene.

As the second Australian employee Albert was involved in the establishment of Celgene in Australia and is currently the Head of Operations and Corporate Affairs.

Deidre MacKechnie

Deidre MacKechnie

CEO, MS Australia

Read more

Deidre is the CEO of MS Australia, the national peak advocacy body for people living with MS in Australia. Deidre commenced with MS Australia in early 2013 in the role of Executive Officer and Company Secretary before her appointment as CEO in 2015. Deidre has had an extensive career in Health, initially training as a nurse which led to clinical education, followed by a move to Human Resources and subsequent roles in senior management. Deidre has post graduate qualifications in Education, Human Resource Management and Governance.

Simon McErlane

Simon McErlane

Regional Medical Director, Alexion Pharmaceuticals

Read more

Dr Simon McErlane is a medically qualified pharmaceutical executive with 17 years of broad management experience across General Management, Medical Affairs, Medical Information, Pharmacovigilance and Clinical Research in Europe, Asia and Australia.

As VP & Asian Site Head of Development for Takeda, Dr McErlane was responsible for all development activities in Asia Pacific Region. He led a team of over 50 staff, representing 9 different functions and 10 different nationalities. He also contributed to Takeda’s global policies on questions of biomedical ethics, including patient-centricity, and was responsible for creating the Clinical Science function in Asia.

Prior to this he was Medical Director of Takeda UK, responsible for medical affairs and pharmacovigilance as well as leading a medical team of both office and field based staff. His first role at Takeda was as the European Medical Affairs Manager for their Cardiovascular portfolio. He started his pharmaceutical medicine career with medical affairs and clinical development roles at Schwarz Pharma UK, Allergan Europe and Pfizer Australia.

Currently with Alexion Pharmaceuticals as the Regional Medical Director, Asia & Australia, Dr McErlane leads a team of over 15 staff across 6 countries. He is heavily involved in keeping decisions, both within Alexion and in government negotiations throughout Asia & Australia, focused on patient outcomes.

Before joining industry Dr McErlane trained in Emergency Medicine at Liverpool Hospital Sydney. He received his MB. BS. BSc. from UNSW, his Diploma of Pharmaceutical Medicine from University of Wales in Cardiff and has attended both INSEAD Singapore and the MGSM Sydney for general management and business education.

Penny Shakespeare

Penny Shakespeare

First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health

Read more

More information coming soon...

Paul White

Paul White

National Sales Manager, Oncology, Novartis Group

Read more

Paul White is a National Sales Manager at Novartis Oncology, Australia. He has worked in Pharmaceuticals for sixteen years, prior to which he was a director at a health and fitness company. Paul has worked across multiple areas of business, was a regular contributor to magazines and presents at industry conferences. He is passionate and enthusiastic about all things, in particular; change management, organisational effectiveness and wine. Paul resides in Sydney with his fiancé Kate and can be contacted at paul7752white@yahoo.com.au

Register Now

Save AU $300 with our Super Early Bird discount. Expires Today!

Alida Rossi

Alida Rossi

Customer Excellence Director, AbbVie

Read more

Alida has a Bachelor of Science and started her career in research.  Although rewarding, a career in the commercial application of her science background was where she has been able to truly apply her knowledge and skill.  Alida has over 25 years in the pharmaceutical industry with roles ranging from Sales, Marketing, Key Account Management, Business Unit Management and at the Director level.  She is currently the Customer Excellence Director at Abbvie and her role encompasses responsibility for Learning, Development, Business Intelligence, Analytics, Innovation and Capability for ANZ.

Josie Downey

Josie Downey

Director, Oncology Business Unit, MSD

Read more

Josie Downey is a Business Unit Director for Oncology at MSD. She began her career as a research scientist in the biotech sector. She has had over 20 years’ experience in the pharmaceutical industry and has worked for a number of pharmaceutical companies, most recently joining MSD in 2011 where she has held roles across various divisions as Business Unit Manager in Specialty Care, Marketing Manager in Primary Care and Director of Commercial Operations.

Elizabeth de Somer

Elizabeth de Somer

Director Policy, Medicines Australia

Read more

More information coming soon...

Ben Hopkins

Ben Hopkins

Commerical Director, Takeda Pharmaceuticals

Read more

A passionate and energetic sales and marketing professional with experience across a broad range of therapeutic areas including oncology, immunology, CNS, cardiovascular, diabetes, osteoporosis and pain, Ben is currently the Commercial Director for Takeda Pharmaceuticals Australia. He leads Sales, Marketing and Commercial Excellence for the organisations Oncology, Gastroenterology and established brands portfolios.

Ben started his pharmaceutical career 20 years ago with MSD as a Medical Representative, taking on roles of increasing responsibility in Sales and Marketing Management for both retail and speciality markets as well as heading up Demand Planning, New Product Planning and Established Brands portfolios. From there Ben enjoyed Marketing and Business Unit Management roles across five different multinational pharmaceutical companies focussing on hospital and speciality markets and biologics, for new products and in-market brands from early phase development and launch through to patent expiry, including hospital generics and biosimilars.

Ben holds an MBA from the Australian Graduate School of Management, and a PhD in Pharmacology from Monash University where he held Medical Research and teaching roles prior to joining the Pharmaceutical industry.

Register Now

Save AU $300 with our Super Early Bird discount. Expires Today!

Richard Clement

Richard Clement

Group Digital Marketing Manager, Aspen Pharma

Read more

Richard has been working in the Pharma and Life Sciences space since graduating as a Molecular Biologist in the late eighties.  He has worked in sales and sales management, marketing and training until joining Aspen in 2005 to take on the challenge of providing digital tools to support both sales force and customers.  Richard is now Group Digital Manager for Aspen Pharma and with his small global team oversees web, mobile and social media aspects of the larger Aspen business.

Luke Cornish

Luke Cornish

Senior Government Relations Manager, MSD

Read more

Luke Cornish is the Government Relations Manager in Australia and is responsible for handling all aspects of policy and political engagement. He joined MSD in 2010 after working as a journalist in the US, UK and Australia.

Luke has worked on a number of policy issues including regulatory reform, biosimilars, and intellectual property rights – specifically data exclusivity and gene patenting. He has a particular interest in oncology, hepatitis C and innovative access models for antibiotics.

Carol Ireland

Carol Ireland

CEO & Managing Director, Epilepsy Action Australia

Read more

A senior executive with an extensive background in the NFP human services sector spanning 35 years; holding chief executive and general management roles; responsibility for client services, revenue generation, branding, marketing, research, communications; significant merger and organisation design experience; providing strong leadership; demonstrated strong commitment to human rights; Fellow of the Australian Institute of Management.

Tammy Lindrum

Tammy Lindrum

Head of Sales and Key Account Management, Sanofi

Read more

Tammy has over 30 years’ experience within the Pharmaceutical and Consumer Industry.

She has worked in Senior Marketing, Medical and Sales Management roles for the last 25 years.

Tammy has a background in Nursing and studied marketing at Kuring Gai College.

During her career she has worked across a broad range of products and disease states including Dermatology, Anti-infective, Cardiology, Hypertension, Allergy, S8 Pain Medications, Anticoagulants, Diabetes treatments, Devices, Hospital based medications as well as Infant formula.

Tammy Launched Loceryl, Posicor and was responsible for the pre marketing of Xenical and Tamiflu during her 10 years at Roche products where she worked as Business Unit Manager.

She worked as Medical Director with Nutricia overseeing Prebiotics introduced into the Karicare range of Infant formula.

Tammy worked on acquisitions at both Roche and Aventis and is a great advocate for change management when implemented well.

Highlights of Tammy’s careers include her twice nominated for the Telstra Business Woman of the year. Both nominations were submitted by the team of Managers she worked with at that time and were based on what they believed to be model leadership and vision.

Tammy also received recognition for the work she completed with the Royal Australasian college of Dermatologists assisting them secure the World Congress of Dermatology...

She was presented with a plaque by Professor Robin Marks recognizing her as an official Ambassador of the Royal Australasian College of Dermatologists for her efforts in assisting the College with their successful bid to secure the Congress for Australia.

Tammy also spent 2 years on the Australian College of Nursing Advisory Board – In this capacity she provided insights into Registered Nurses working outside of the Hospital system.

Tammy currently works with Sanofi as Head of Sales and Key Account Management for the General Medicine Business Unit. She has been with Sanofi for 9 years.

Roberto Castro

Roberto Castro

Commercial Operations Manager, iNova Pharma

Read more

More information coming soon...

Register Now

Save AU $300 with our Super Early Bird discount. Expires Today!

Sue MacLeman

Sue MacLeman

CEO, MTPConnect

Read more

Sue MacLeman is the CEO of the Medical Technology and Pharmaceutical Industry Innovation Growth Centre Ltd (MTPConnect) . She is also a non-executive director at Oventus Medical Ltd and Reproductive Health Sciences Ltd. Previously she has served as Mesoblast Ltd Head of Commercial and Senior Vice President Corporate. She has more than 25 years’ experience as a pharmaceutical executive with roles in corporate, medical, marketing, business development, and sales management at Schering-Plough Corporation (now Merck), Amgen and Bristol-Myers Squibb. Sue has also served as CEO and director of several ASX and NASDAQ listed companies.

Damian Byers

Damian Byers

Director of Human Resources, Mundipharma

Read more

More information coming soon...

Paul Cross

Paul Cross

Publisher, PharmaDispatch

Read more

Paul Cross is the publisher of PharmaDispatch and BiotechDispatch, online journals focused on providing news and analysis concerning the Australian pharmaceutical and biotechnology sectors. He has over 15 years experience in health care, having served in senior roles in government and the private sector.

As a senior adviser to two Australian health ministers over 5 years, he had policy responsibility for the PBS, pharmacy, private health insurance and private hospitals.

He then served in senior Australian and global public affairs roles for three pharmaceutical companies, including for Merck & Co in the US.

He established PharmaDispatch in 2012 with the goal of providing news and analysis from the perspective of the pharmaceutical sector. Since launch, the publication has been cited as a source by the Australian Financial Review and in News Corp publications. It has also been referenced in the Federal Parliament.

Kylie Bromley

Kylie Bromley

Associate Director of Sales & Marketing, Biogen

Read more

Kylie is currently the Associate Director of Sales and Marketing for Rare Diseases at Biogen Australia and New Zealand.   She is an accomplished senior commercial leader with diverse experience in the biopharmaceutical industry across marketing, sales management, market access, and medical affairs.   In her most recent role prior to joining Biogen, Kylie was National Sales Manager – Haematology/Oncology at Amgen Australia, leading a large highly-functioning team to deliver results in highly competitive markets through the promotion of Neulasta®, XGEVA® and Vectibix®.  This role was preceded by her Marketing Manager role in nephology where she had oversight both Aranesp® and Sensipar®.   

Along with extensive commercial experience spanning the entire product lifecycle (pre-launch, launch and mature phase) in a variety of therapeutic areas including haematology/oncology, nephrology, osteoporosis and most recently in rare paediatric neurological disorders.   Kylie also holds a PhD in Pharmacology and a Bachelor degree in Science (Honors) from the University of Melbourne, and a postgraduate certificate in Marketing Management from the Macquarie Graduate School of Management.

She has a passion for science and innovation; with a desire to ensure patients have access to products and services that can support better outcomes.

Adrian Bootes

Adrian Bootes

Assistant Secretary, Prescription Medicines Authorisation Branch, Therapeutic Goods Administration

Read more

More information coming soon...

Register Now

Save AU $300 with our Super Early Bird discount. Expires Today!

Shaun Holmgreen

Shaun Holmgreen

Head - Operational Excellence, UCB

Read more

More information coming soon...

Jessica Danaher

Jessica Danaher Galderma

Brand Manager - Prescription, Galderma

Read more

More information coming soon...

Dr Munro Neville

Dr. Munro Neville

Chief Medical Officer, Sonic Clinical Services

Read more

Dr Neville specialises in the design and execution of disease management programs, interventional clinical trials and observational research studies in the primary care settings.  At Pretium, a disease management and research firm he cofounded in 2003, he developed algorithms for the accurate identification from electronic health records of eligible patients for recruitment to programs and studies.  He adapted this approach for use in Sonic Clinical Service’s disease management programs, the WellNet suite of clinical and behavioural interventions.  Munro designed these stepped care programs for patients who have complex needs, multimorbidity or chronic diseases, as well as those who are at higher risk of developing a chronic disease. 

Munro has held a senior appointment with the Mayne Group, then an operator of a large chain of private and public hospitals in Australia and Indonesia, radiology and pathology services and GP practices. At Mayne he developed the group’s ability to undertake detailed clinical costing activities, changed the hospital contracting model to casemix funding (facilitated by the clinical costing knowledge) and introduced the philosophy of evidence based practice.  He also expanded the company’s capacity to undertake health technology assessment to support investment and funding negotiations.

Prior to coming to Australia, he served as Assistant Medical Director for a large private health insurance firm in the UK, AXA PPP healthcare. His work there included analysis of the effects of price signals on health care utilisation, the development of new insurance products and negotiating increased access to cancer centre services for members.

Munro gained his MBBS from St Bartholomew’s Hospital, London, an MBA from the London Business School and an MSc in health care decision analysis from the London School of Economics/London School of Hygiene and Tropical Medicine (joint degree). 

Chris Barakat

Chris Barakat

Director of Business Development, Healthshare

Read more

Chris joined Healthshare in 2013 and leads the company's Business Development efforts. Chris’ key focus areas within Healthshare involve developing viable commercial plans, growing partnerships with key stakeholders and implementing strategies with an elite field force.

Chris comes from a diverse commercial healthcare background. His previous roles include sales in Pfizer's Cardiology, Metabolic and Urology portfolios, Device Technologies in Cardiology, Cardiothoracic Surgery, Respiratory Medicine, ICU, Nuclear Medicine & Orthopaedics and Informa Healthcare with Multinational Pharma, Biotechnology, Venture Capital, Research Institutes and Generic Pharma across Australia and Asia Pacific.

Julia Ballard

Julia Ballard

Senior Journal Publishing Manager, Wiley

Read more

More information coming soon...

Glenn Montgomery

Glenn Montgomery

Director, Patient Access and Healthcare Systems, Novartis

Read more

Glenn Montgomery has worked within the Australian Pharmaceutical Industry for over 30 years.

He is an experienced business leader having worked with large and small teams in companies such as Wyeth, MSD, Abbott and Merck Serono, across diverse portfolios including Women’s health, IVF, Musculoskeletal, Virology, Endocrinology, Neurology and Cardiovascular.

Glenn joined Novartis in 2013 and has lead the evolution of the Immunology & Dermatology Franchise, culminating in the successful launch of new products in dermatology and rheumatology to complement the existing transplant portfolio.

He now heads up the Novartis Patient Access and Healthcare Systems team which provides patient access and optimizes healthcare systems for the benefit of Australian and New Zealand patients.

Glenn holds a Bachelor of Science (Biological Sciences) from Macquarie University and is a qualified Podiatrist.

Novartis
Simon Fisher

Simon Fisher

Chief Scientific Officer, Novartis

Read more

Simon has nearly 20 years’ experience in the biopharmaceutical industry. After graduating in Medicine at Monash University in Melbourne, Simon completed his MBA.  Since leaving clinical medicine, Simon has held roles in Medical Affairs, Clinical development, Regional Clinical Operations and General Management.  Simon has lead both local and regional teams whilst working in Australia, the US, and China.  Simon is currently the Chief Scientific Officer at Novartis Australia and New Zealand.

James Dromey

James Dromey PhD

Chief Operating Officer, Murdoch Childrens Research Institute

Read more

James is Chief Operating Officer at Murdoch Children’s Research Institute (MCRI), one of Australia’s largest research institutes with close to 2000 researchers working across all areas of child and adolescent health.

 

Prior to this he was General Manager – Business Development & Strategy at MCRI, where he led the development and commercialisation of a pipeline of more than 400 research projects on new drugs, devices, diagnostics and digital health technologies.

 

James championed MCRI’s drive into digital health and has positioned the Institute as an international leader in this area. He led the development and implementation of a new model in medical research that facilitates greater collaboration and knowledge transfer across health and technology, engineering and ICT sectors.

 

James has over 17 years’ experience in health and medical research, both as a research scientist and in technology innovation and commercialisation. Previously, James was Business Development Manager at the Walter & Eliza Hall Institute in Melbourne, where he led a number of strategic collaborations with industry partners ranging from SMEs, to top 5 international pharmaceutical and Fortune 500 companies. As a research scientist he was part of a team that developed a first-in-class vaccine for celiac disease that went on to raise over $35 million and is now in clinical trials. His work has resulted in the filing of three patent applications, two of which have been commercialised. James is currently a Non-Executive Director of GI Therapies, an unlisted spin-out from MCRI.

Don’t miss out in 2017

Have Your Say: We would like to hear from you if you have any ideas, opportunities or questions.

If you are interested in attending please contact us on the below details.

Anza Asahara

Anza Asahara

Project Director
eyeforpharma

Phone: +44 207 422 4312

Email: anza@eyeforpharma.com

Don't miss out - register now

Discount ends TODAY! Save AU $300 with our Super Early Bird discount. Don't miss out!